BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 3901330)

  • 1. Protection against systemic infections with various Candida species elicited by vaccination with Candida albicans ribosomes.
    Segal E; Nussbaum S; Barr-Nea L
    Sabouraudia; 1985 Aug; 23(4):275-85. PubMed ID: 3901330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of protection against candidiasis in tumor-bearing mice by vaccination with Candida albicans ribosomes.
    Segal E; Spungin A; Levy R; Barr-Nea L
    J Med Vet Mycol; 1987 Dec; 25(6):355-63. PubMed ID: 3325628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experimental vaccination with Candida albicans ribosomes in cyclophosphamide-treated animals.
    Segal E; Sandovsky-Losica H
    Sabouraudia; 1981 Dec; 19(4):267-73. PubMed ID: 7034238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunological and pathological observations with Candida albicans-infected animals.
    Kuttin ES; Müller J; Douchet C; Vogt A
    Sabouraudia; 1983 Sep; 21(3):185-94. PubMed ID: 6356407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunisation with the glycolytic enzyme enolase confers effective protection against Candida albicans infection in mice.
    Li Wq; Hu Xc; Zhang X; Ge Y; Zhao S; Hu Y; Ashman RB
    Vaccine; 2011 Jul; 29(33):5526-33. PubMed ID: 21645574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Candida albicans mannan extract-protein conjugates induce a protective immune response against experimental candidiasis.
    Han Y; Ulrich MA; Cutler JE
    J Infect Dis; 1999 Jun; 179(6):1477-84. PubMed ID: 10228070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of antibodies against Candida albicans ribosomes by the enzyme linked immunosorbent assay.
    Levy R; Segal E; Eylan E
    Mycopathologia; 1984 Sep; 87(3):167-70. PubMed ID: 6392887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune responses elicited by vaccinations with Candida albicans ribosomes in cyclophosphamide treated animals.
    Segal E; Sandovsky-Losica H; Nussbaum S
    Mycopathologia; 1985 Feb; 89(2):113-8. PubMed ID: 3887173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Escheriosome mediated cytosolic delivery of Candida albicans cytosolic proteins induces enhanced cytotoxic T lymphocyte response and protective immunity.
    Chauhan A; Swaleha Z; Ahmad N; Farazuddin M; Vasco A; Abida M; Mohammad O
    Vaccine; 2011 Jul; 29(33):5424-33. PubMed ID: 21645572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of two Candida mannan vaccines: the role of complement in protection against disseminated candidiasis.
    Han Y; Rhew KY
    Arch Pharm Res; 2012 Nov; 35(11):2021-7. PubMed ID: 23212645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prophylactic vaccination with phage-displayed epitope of C. albicans elicits protective immune responses against systemic candidiasis in C57BL/6 mice.
    Yang Q; Wang L; Lu DN; Gao RJ; Song JN; Hua PY; Yuan DW
    Vaccine; 2005 Jul; 23(31):4088-96. PubMed ID: 15963364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of adaptive immunity in the pathogenesis of Candida albicans keratitis.
    Zhang H; Chen H; Niu J; Wang Y; Xie L
    Invest Ophthalmol Vis Sci; 2009 Jun; 50(6):2653-9. PubMed ID: 19218608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Active and passive immunization against oral Candida albicans infection in a murine model.
    Farah CS; Ashman RB
    Oral Microbiol Immunol; 2005 Dec; 20(6):376-81. PubMed ID: 16238599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Production of anti-Candida antibodies in mice with gut colonization of Candida albicans.
    Tansho S; Abe S; Ishibashi H; Mitsuya M; Wada K; Ikeda T; Suegara N; Koshio O; Ono Y; Yamaguchi H
    Mediators Inflamm; 2004 Jun; 13(3):189-93. PubMed ID: 15223610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Saccharomyces as a vaccine against systemic candidiasis.
    Liu M; Clemons KV; Johansen ME; Martinez M; Chen V; Stevens DA
    Immunol Invest; 2012; 41(8):847-55. PubMed ID: 22686468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic candidiasis in mice immunized with Candida albicans ribosomes.
    Levy R; Segal E; Barr-Nea L
    Mycopathologia; 1985 Jul; 91(1):17-22. PubMed ID: 3900730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccination with Secreted Aspartyl Proteinase 2 Protein from
    Shukla M; Rohatgi S
    Infect Immun; 2020 Sep; 88(10):. PubMed ID: 32661125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liposomes containing Candida albicans ribosomes as a prophylactic vaccine against disseminated candidiasis in mice.
    Eckstein M; Barenholz Y; Bar LK; Segal E
    Vaccine; 1997 Feb; 15(2):220-4. PubMed ID: 9066041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific inhibition of Candida albicans growth in vitro by antibodies from experimental Candida keratitis mice.
    Zhang H; Jia C; Xi H; Li S; Yang L; Wang Y
    Exp Eye Res; 2011 Jul; 93(1):50-8. PubMed ID: 21540028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of Toll-like receptors and C-type lectins for vaccination against Candida albicans.
    Ferwerda G; Netea MG; Joosten LA; van der Meer JW; Romani L; Kullberg BJ
    Vaccine; 2010 Jan; 28(3):614-22. PubMed ID: 19887129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.